A detailed history of Pensionmark Financial Group, LLC transactions in Geron Corp stock. As of the latest transaction made, Pensionmark Financial Group, LLC holds 1,029,553 shares of GERN stock, worth $3.44 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,029,553
Previous 1,029,553 -0.0%
Holding current value
$3.44 Million
Previous $4.67 Million -0.0%
% of portfolio
0.15%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $4.25 Million - $5.09 Million
1,019,510 Added 10151.45%
1,029,553 $4.67 Million
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $17,424 - $34,252
-9,957 Reduced 49.79%
10,043 $33,000
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $42,200 - $65,600
20,000 New
20,000 $42,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Pensionmark Financial Group, LLC Portfolio

Follow Pensionmark Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionmark Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pensionmark Financial Group, LLC with notifications on news.